The complex relationship between integrins and oncolytic herpes Simplex Virus 1 in high-grade glioma therapeutics.
The complex relationship between integrins and oncolytic herpes Simplex Virus 1 in high-grade glioma therapeutics.
复制标题
DOI:
10.1016/j.omto.2022.05.013
复制
发表时间:
2022-09-15
期刊:
影响因子:
--
通讯作者:
Yoo, Ji Young
中科院分区:
文献类型:
--
作者:
Rivera-Caraballo, Kimberly Ann;Nair, Mitra;Lee, Tae Jin;Kaur, Balveen;Yoo, Ji Young
High-grade gliomas (HGGs) are lethal central nervous system tumors that spread quickly through the brain, making treatment challenging. Integrins are transmembrane receptors that mediate cell-extracellular matrix (ECM) interactions, cellular adhesion, migration, growth, and survival. Their upregulation and inverse correlation in HGG malignancy make targeting integrins a viable therapeutic option. Integrins also play a role in herpes simplex virus 1 (HSV-1) entry. Oncolytic HSV-1 (oHSV) is the most clinically advanced oncolytic virotherapy, showing a superior safety and efficacy profile over standard cancer treatment of solid cancers, including HGG. With the FDA-approval of oHSV for melanoma and the recent conditional approval of oHSV for malignant glioma in Japan, usage of oHSV for HGG has become of great interest. In this review, we provide a systematic overview of the role of integrins in relation to oHSV, with a special focus on its therapeutic potential against HGG. We discuss the pros and cons of targeting integrins during oHSV therapy: while integrins play a pro-therapeutic role by acting as a gateway for oHSV entry, they also mediate the innate antiviral immune responses that hinder oHSV therapeutic efficacy. We further discuss alternative strategies to regulate the dual functionality of integrins in the context of oHSV therapy. Integrins mediate extracellular-to-intracellular signaling and are important for HSV-1 entry. Although the latter is crucial for an efficacious oHSV therapeutic outcome, it can lead to undesirable antiviral immune responses. Therefore, fine-tuning the antagonistic effects of integrins against oHSV while maintaining viral entry efficiency will promote the antitumoral response to maximize oHSV therapeutic efficacy.
登录
查看更多内容
影响因子:
8
作者:
Blandin, Anne-Florence;Da Silva, Elisabete Cruz;Lehmann, Maxime
通讯作者:
Lehmann, Maxime
影响因子:
8.4
作者:
Danilucci, Tais M.;Santos, Patty K.;Selistre-de-Araujo, Heloisa S.
通讯作者:
Selistre-de-Araujo, Heloisa S.
DOI:
10.1016/j.bbrc.2020.12.050
发表时间:
2021-01-15
影响因子:
3.1
作者:
Fujita, Motomichi;Sasada, Manabu;Fukai, Fumio
通讯作者:
Fukai, Fumio
影响因子:
11.2
作者:
Carbonell WS;DeLay M;Jahangiri A;Park CC;Aghi MK
通讯作者:
Aghi MK
影响因子:
4.6
作者:
Friedman GK;Bernstock JD;Chen D;Nan L;Moore BP;Kelly VM;Youngblood SL;Langford CP;Han X;Ring EK;Beierle EA;Gillespie GY;Markert JM
通讯作者:
Markert JM